Data as of Sep 12
| +0.09 / +0.14%|
The 16 analysts offering 12-month price forecasts for Eli Lilly and Co have a median target of 63.00, with a high estimate of 73.00 and a low estimate of 60.00. The median estimate represents a -3.48% decrease from the last price of 65.27.
The current consensus among 20 polled investment analysts is to Hold stock in Eli Lilly and Co. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.